Johnson & Johnson
XHAN:JNJ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Johnson & Johnson (JNJ) under the Base Case is EUR per share.
Compared with the current market price of 250.45 EUR, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Johnson & Johnson Does
Johnson & Johnson is a healthcare company that sells prescription medicines and medical devices. Its drug business focuses on treatments in areas such as immunology, oncology, neuroscience, and infectious disease, while its medical technology business sells products used in surgery, orthopedics, vision care, and other hospital and clinic settings. It no longer includes the consumer health brands that were separated into Kenvue.
- Headquarters
- United States of America US
- Employees
- 138 200
- IPO date
- Sep 25, 1944
Johnson & Johnson has a wide economic moat
Patents and exclusive drug rights prevent rivals from copying important treatments, while hospitals’ investment in specialized equipment and staff training makes changing suppliers costly. Johnson & Johnson combines these protections across medicines and medical devices rather than depending on a single product.
Read the full moat analysis
Revenue & Expenses Breakdown
Johnson & Johnson
Earnings Waterfall
Johnson & Johnson
What is the Intrinsic Value of one JNJ stock?
The intrinsic value for Johnson & Johnson (JNJ) under the Base Case is EUR.
Is JNJ stock undervalued or overvalued?
Compared with the current market price of 250.45 EUR, the stock appears .
